Make a donation

MCRN Clinical Trials

Bringing Game-Changing Therapies to Canadian Patients: Updates on the Myeloma Canada Research Network's Active Clinical Trials

The Myeloma Canada Research Network (MCRN) brings innovative Canadian-designed clinical trials to hundreds of patients in 24 centres in 9 provinces across Canada. All MCRN trials are designed to improve Canadian myeloma treatment protocols, influence government decision-making policies for drug reimbursement and provide access to game-changing therapies that would otherwise not be available. The goal of these initiatives is to improve overall outcomes for Canadian patients living with myeloma.

MCRN 001 – The BuMel Trial

MCRN 002 – The STOMP Trial

MCRN 003 – The KCd Trial


MCRN 005 – The BOSTON Trial